Clinical Trial Update: Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the immunogenicity and safety of etanercept produced with a modified manufacturing process in adults with plaque psoriasis; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Amgen | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2016-12-29